Literature DB >> 29511621

Robust DNA repair in PAXX-deficient mammalian cells.

Alisa Dewan1,2,3, Mengtan Xing1, Marie Benner Lundbæk1, Raquel Gago-Fuentes1, Carole Beck1, Per Arne Aas1, Nina-Beate Liabakk1, Siri Sæterstad1, Khac Thanh Phong Chau1, Bodil Merete Kavli1, Valentyn Oksenych1,4.   

Abstract

To ensure genome stability, mammalian cells employ several DNA repair pathways. Nonhomologous DNA end joining (NHEJ) is the DNA repair process that fixes double-strand breaks throughout the cell cycle. NHEJ is involved in the development of B and T lymphocytes through its function in V(D)J recombination and class switch recombination (CSR). NHEJ consists of several core and accessory factors, including Ku70, Ku80, XRCC4, DNA ligase 4, DNA-PKcs, Artemis, and XLF. Paralog of XRCC4 and XLF (PAXX) is the recently described accessory NHEJ factor that structurally resembles XRCC4 and XLF and interacts with Ku70/Ku80. To determine the physiological role of PAXX in mammalian cells, we purchased and characterized a set of custom-generated and commercially available NHEJ-deficient human haploid HAP1 cells, PAXXΔ, XRCC4Δ , and XLFΔ . In our studies, HAP1 PAXXΔ cells demonstrated modest sensitivity to DNA damage, which was comparable to wild-type controls. By contrast, XRCC4Δ and XLFΔ HAP1 cells possessed significant DNA repair defects measured as sensitivity to double-strand break inducing agents and chromosomal breaks. To investigate the role of PAXX in CSR, we generated and characterized Paxx-/- and Aid-/- murine lymphoid CH12F3 cells. CSR to IgA was nearly at wild-type levels in the Paxx-/- cells and completely ablated in the absence of activation-induced cytidine deaminase (AID). In addition, Paxx-/- CH12F3 cells were hypersensitive to zeocin when compared to wild-type controls. We concluded that Paxx-deficient mammalian cells maintain robust NHEJ and CSR.

Entities:  

Keywords:  CH12F3; HAP1; IgA; class switch recombination; etoposide; zeocin

Year:  2018        PMID: 29511621      PMCID: PMC5832976          DOI: 10.1002/2211-5463.12380

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.693


p53‐binding protein 1 activation‐induced cytidine deaminase ataxia telangiectasia mutated class switch recombination DNA‐dependent protein kinase, catalytic subunit DNA double‐strand break horseradish peroxidase immunoglobulin interleukin Ku70/Ku80 heterodimer lipopolysaccharide nonhomologous end joining paralog of XRCC4 and XLF recombination activating genes 1 and 2 severe combined immunodeficiency telomere fluorescence in situ hybridization uracil N‐glycosylase XRCC4‐like factor XRCC4‐like small protein X‐ray cross‐complementing protein 4 Nonhomologous DNA end joining (NHEJ) is a molecular pathway that recognizes and fixes DNA double‐strand breaks (DSBs) throughout the cell cycle. NHEJ is the key DNA repair pathway involved in B‐ and T‐lymphocyte development through V(D)J recombination, and B‐cell specialization via class switch recombination (CSR) 1. Core NHEJ factors include Ku70, Ku80, XRCC4, and DNA ligase 4. Deficiency in core factors nearly completely abrogates classical NHEJ, whereas alternative end joining is still possible 2. The Ku70/Ku80 heterodimer (Ku) interacts with downstream NHEJ factors. Among others, Ku interacts with XRCC4‐like factor (XLF, or Cernunnos, or NHEJ1), paralog of XRCC4 and XLF (PAXX, or XLS, or C9orf142), and DNA‐dependent protein kinase, catalytic subunit (DNA‐PKcs). Both XLF 3, 4 and PAXX 5, 6, 7 were discovered due to their similarity with XRCC4. While genetic inactivation of Xrcc4 completely abrogates classical NHEJ and is embryonic lethal in mice 8, inactivation of Xlf or Paxx has only modest or no effect on mouse development, due to complex functional redundancy in the DNA repair pathway 9. XLF functionally overlaps with PAXX, which is demonstrated in both cell lines and mouse models. For example, combined inactivation of Xlf and Paxx in mice leads to synthetic lethality 10, 11. In addition, functional overlap between XLF and PAXX in DNA repair was demonstrated using chicken DT40 cell lines 7, and in the NHEJ‐dependent V(D)J recombination using murine pro‐B cells 11, 12, 13, 14. Furthermore, XLF functionally overlaps with DNA damage response factors, protein kinases ATM and DNA‐PKcs, and their substrates, H2AX and 53BP1 15, 16, 17, 18, 19. Currently, the role of PAXX in DSB response, particularly in human cells, is an unsolved question, and it attracted attention of several research groups worldwide. Class switch recombination is a process in which mature B lymphocytes edit their immunoglobulin heavy‐chain genes in response to antigen stimuli, leading to production of new antibody isotypes with altered downstream effector functions in the immune response. CSR is initiated by transcription‐dependent recruitment of activation‐induced cytidine deaminase (AID) to the cytosine‐rich switch regions of immunoglobulin genes. Upon AID‐induced deamination, cytosines in DNA repair are converted to deoxyuracils, which are then removed by the uracil DNA N‐glycosylase (UNG). Deamination by AID, uracil excision by UNG, and strand incision by AP endonuclease occur simultaneously on both strands, thus leading to DSBs which are repaired by NHEJ 20, 21. Deficiency in core XRCC4 or accessory XLF factors, respectively, leads to a twofold to threefold reduction in CSR 22, 23. However, the role of recently described accessory NHEJ factors in CSR is not determined yet and is an open question. Here, using a CRISPR/Cas9 approach, we obtained PAXX‐deficient human HAP1 cells (PAXX , Horizon Discovery), generated murine lymphoid CH12F3 cells (Paxx −/−) and analyzed several aspects related to DNA repair efficiency of these cell lines, including proliferation, sensitivity to DNA‐damaging chemicals, genomic stability, and CSR. We found that PAXX HAP1 cells are not hypersensitive to etoposide and zeocin and do not possess increased levels of genomic instability when compared to WT parental line. Moreover, Paxx −/− CH12F3 cells demonstrated ability to perform robust CSR to IgA when compared to WT and Aid −/− controls.

Materials and methods

HAP1 cells

All HAP1 cells (Horizon Discovery) were made commercially available and handled according to the manufacturer's instructions: XRCC4 (HZGHC000428c019), XLF (NHEJ1 , HZGHC000426c004, and HZGHC000426c017), and PAXX (C9orf142 , HZGHC004376c005, and HZGHC004376c006).

Antibodies

For western blot (WB), we used the following antibodies: rabbit polyclonal anti‐PAXX/C9orf142 (NovusBio, Littleton, CO, USA; NBP1‐94172, dilution 1 : 1000); rabbit polyclonal anti‐XLF (Bethyl, A300‐730A, 1 : 2000); swine polyclonal anti‐rabbit Ig‐HRP (Dako antibodies, Dako, Glostrup, Denmark; #P0399, 1 : 5000); mouse monoclonal anti‐XRCC4 (NovusBio, NBP1‐48053, 1 : 2000); mouse monoclonal anti‐β‐actin (Abcam, Cambridge, UK; ab8226, 1 : 2000); rabbit polyclonal anti‐mouse Ig‐HRP (Dako antibodies, #P0260, 1 : 5000); goat polyclonal anti‐mouse Ig‐HRP (Dako antibodies, #P0447, 1 : 5000); rat monoclonal anti‐AID (Active Motif, Carlsbad, CA, USA; #39886, 1 : 500) and secondary anti‐rat IgG, HRP‐linked (Cell signaling #7077, Cell Signaling, Leiden, The Netherlands; 1 : 5000); rabbit polyclonal anti‐UNG (custom‐made against murine UNG, 2 μg·mL−1); and IRDye 800CW anti‐rabbit IgG (Licor, Lincoln, NE, USA; #925‐32211, 1 : 15 000).

Proliferation assay

HAP1 cells were plated 5 × 104 cells·mL−1 in triplicate in 6‐well plates and counted every 24 hours using Countess™ Automated Cell Counter (Invitrogen, Carlsbad, CA, USA) with Trypan blue stain (Invitrogen) and bright‐field detection. CH12F3 cells were plated 5 × 104 cells·mL−1 in triplicate in 6‐well plates and counted at 24 hours and every 12 hours until 60 hours as described for HAP1.

Cell survival assay

HAP1 cell sensitivity to DSB‐inducing agents was tested by colony formation assay. Cells were counted, and 100 cells were plated in 2 mL of medium per well, in 6‐well plates on day 0 in triplicates. Etoposide (Sigma‐Aldrich, St. Louis, MO, USA; #E1383) or zeocin (InvivoGen, #15A27‐MM) was added on day 1 at indicated concentrations, and mock‐treated control was used as a reference. On day 10, medium was removed and colonies were stained with 1 mL per well 0.5% crystal violet solution (0.5 g crystal violet powder, 25 mL methanol, 75 mL dH2O) for 15 minutes with perturbation 24, 25. After staining crystal violet solution was removed, plates were washed with tap water and colonies were counted. CH12F3 sensitivity to zeocin was assayed with PrestoBlue (ThermoFischer, Waltham, MA, USA), according to the manufacturer's instructions

Telomeric in situ hybridization

Telomeric in situ hybridization (T‐FISH) was performed as previously described 16, 17, 18. Metaphase images were captured using a Zeiss TRIF3 microscope equipped with a CCD camera and a 100× objective lens.

Generation of Paxx and Aid CH12F3 cell lines

All oligonucleotides corresponding to sgRNAs were cloned into the plasmid vector LentiCRISPR v2 (Addgene plasmid #52961). The following sgRNAs were used to target exon 2 of the Paxx gene: TGACGGACGCCGCCGAGCTC, TCTCGCCTGACAGCCTGGCG, and CTCGGCGGCGTCCGTCACAC, using the protocol described in Ref. 26. Upon lentiviral‐mediated transduction of parental WT CH12F3, the cells were subcloned and up to 200 clones from each of the three sgRNAs were screened by WB and cells lacking PAXX signal were kept for experiments. Mock‐treated and parental WT CH12F3 cells were used as control. The Aid −/− CH12F3 cells were obtained by targeting exon 2 of the Aid (Aicda) gene with AGGGACGGCATGAGACCTAC sgRNA. The cells were subcloned, stimulated to CSR, and screened for AID expression using WB. The cells lacking AID signal detected by WB were verified by DNA sequencing and functional assay (CSR).

CSR to IgA

Class switch recombination to IgA was induced as previously described 2, 27.

Results

Generation and characterization of PAXX , XLF , and XRCC4 HAP1 cells

Three XRCC4‐like NHEJ factors have been described in DSB repair: PAXX, XLF, and XRCC4. To characterize the sensitivity of DSB repair in human cells deficient in these factors, we obtained knockout HAP1 cells (Materials and methods). These cells were produced using the CRISPR/Cas9 gene‐editing approach, and the genetic changes were sequence‐verified by Horizon Discovery. In our studies, we used two PAXX , two XLF , and one XRCC4 HAP1 cell lines carrying indel mutations (Fig. 1A and Materials and methods). We verified the absence of corresponding proteins by WB. No band corresponding to PAXX was detected in PAXX , and no XLF band was observed in XLF and no XRCC4 in XRCC4 cells (Fig. 1B–D). All PAXX , XLF , and XRCC4 HAP1 cells in our experiments proliferated slower than WT parental controls (Fig. 1E), in line with previously observed cell growth defect in PAXX −/−, XLF −/−, and XRCC4 −/− DT40 cell lines 7.
Figure 1

DNA repair efficiency in PAXX and XRCC4 HAP1 cells. (A) NHEJ‐deficient HAP1 cells were produced by Horizon Discovery. Two PAXX lines carry either 1bp insertion or 2bp deletion in exon 4. XRCC4 line carries 8bp deletion in exon 2. Two XLF lines carry either 10bp or 4bp deletion in exon 3. (B, C, D) WB assay detected no PAXX protein in PAXX cells (B), no XRCC4 in XRCC4 cells (C) and no XLF in XLF cells (D). (E) Proliferation of HAP1 cells of indicated genotypes. We present summary of three experiments, data from two PAXX and two XLF lines were pooled. Error bars are S.D. (F, G) Sensitivity of HAP1 cells of indicated genotypes to double‐strand break‐inducing agents Zeocin (F) and Etoposide (G). Numbers represent count of colonies normalized to mock‐treated controls. Four experiments were performed. Data from two PAXX and two XLF lines were pooled. Error bars are S.D. (H) Genomic instability in HAP1 cells of indicated genotypes. Count of chromosomal breaks and chromatid breaks; average breaks per cell are shown for reference.

DNA repair efficiency in PAXX and XRCC4 HAP1 cells. (A) NHEJ‐deficient HAP1 cells were produced by Horizon Discovery. Two PAXX lines carry either 1bp insertion or 2bp deletion in exon 4. XRCC4 line carries 8bp deletion in exon 2. Two XLF lines carry either 10bp or 4bp deletion in exon 3. (B, C, D) WB assay detected no PAXX protein in PAXX cells (B), no XRCC4 in XRCC4 cells (C) and no XLF in XLF cells (D). (E) Proliferation of HAP1 cells of indicated genotypes. We present summary of three experiments, data from two PAXX and two XLF lines were pooled. Error bars are S.D. (F, G) Sensitivity of HAP1 cells of indicated genotypes to double‐strand break‐inducing agents Zeocin (F) and Etoposide (G). Numbers represent count of colonies normalized to mock‐treated controls. Four experiments were performed. Data from two PAXX and two XLF lines were pooled. Error bars are S.D. (H) Genomic instability in HAP1 cells of indicated genotypes. Count of chromosomal breaks and chromatid breaks; average breaks per cell are shown for reference.

Sensitivity of PAXX , XLF , and XRCC4 HAP1 cells to DNA‐damaging agents

A number of anticancer agents are used to induce DSBs. To determine whether our knockout HAP1 cells possess hypersensitivity to DSBs when compared to WT parental cells, we treated the cells with zeocin and etoposide, respectively. Both XLF and XRCC4 cells were hypersensitive to zeocin at concentrations ranging from 0.5 to 4 μg·mL−1 while sensitivity of PAXX cells was not different from WT control. Higher doses of zeocin were lethal for all the cell lines (Fig. 1F). Similarly, XLF and XRCC4 HAP1 cells were hypersensitive to etoposide at concentrations ranging from 5 to 80 nM while PAXX cells were modestly sensitive to etoposide (Fig. 1G).

Genomic instability in PAXX , XLF , and XRCC4 HAP1 cells

Inactivation of NHEJ genes usually leads to accumulation of translocations, chromatin, and chromosomal breaks 1. To determine levels of genomic instability in PAXX , XLF , and XRCC4 HAP1 cells, we performed T‐FISH analysis. We observed relatively high background levels of genomic instability (measured as chromosomal and chromatid breaks) in WT HAP1 cells with 0.16 break per cell on average, which is higher than we previously observed in NHEJ‐proficient murine cells (0.00–0.10 breaks per cell, 16, 17, 18) (Fig. 1H). Genomic instability nearly did not increase in PAXX cells with 0.18 breaks per cell. Furthermore, we observed 0.31 breaks per cell in XLF and 0.62 breaks per cell in XRCC4 HAP1 cells. This finding suggests that XRCC4 and XLF have major role to maintain genomic stability in HAP1 cells, while PAXX has no obvious function in this process.

Class Switch Recombination to IgA in Paxx and Aid CH12F3 cells

Most of the core and accessory NHEJ factors are required for efficient CSR 1. To elucidate the role of PAXX in CSR, we applied CRISPR/Cas9 to generate frame shift in exon 2 of Paxx gene in murine B‐cell line CH12F3 (Materials and methods). We screened individual clones by WB and selected three Paxx −/− subclones originating from independent sgRNAs. In six experiments, Paxx −/− and WT cells switched to IgA with certain variation between each experiment and cell line (Fig. 2A–C). On average, at day 4 after the CSR stimulation, 43% of Paxx −/− cells expressed IgA, which was similar or lower when compared to WT controls, on average 49% of IgA on day 4, p = 0.1707 (Fig. 2B). To establish background levels in our CSR experiments, we generated and used Aid −/− CH12F3 cells by targeting exon 2 of Aid gene by CRISPR/Cas9 approach. Background levels of IgA detected in Aid −/− cells varied from 0.4% to 1.0% with average 0.8%, which was significantly lower when compared to both Paxx −/− and WT lines (p < 0.0001, ****; Fig. 2A, B, D). These experiments are in line with previously published observations that inactivation of Paxx in CH12F3 cell lines has no effect on the CSR to IgA 14, and Paxx null mice possess normal CSR to various isotypes including the IgG1, IgG2, and IgG3 10, 11.
Figure 2

Robust CSR to IgA+ in Paxx −/− CH12F3 cells. (A) Example of CH12F3 FACS plot of indicated genotypes 4 days after stimulation with anti‐CD40, IL‐4, and TGF‐β. (B) CSR summary of six experiments of two WT (pooled) and three Paxx −/− (pooled) CH12F3 cells. Aid −/− CH12F3 cells were used to establish background levels of experiments. Multiple comparisons between groups were performed using GraphPad Prism 7.03 (La Jolla, CA, USA) and one‐way ANOVA. (C) Detection of PAXX protein by WB in WT and Paxx −/− CH12F3 cells. β‐Actin was used as a loading control. (D) Detection of AID protein using WB. UNG2 was used as a loading control. ‘+’ indicates cells stimulated with anti‐CD40, IL‐4 and TGF‐β. ‘−’ indicates unstimulated cells. AID expression was induced and detected in stimulated WT cells; AID band was absent before and after stimulation of Aid −/− cells. (E) Sensitivity of WT and Paxx −/− cells to DSB‐inducing agent zeocin. Numbers represent cell count normalized to mock‐treated controls. Three experiments with three independent clones were performed. Error bars represent SD.

Robust CSR to IgA+ in Paxx −/− CH12F3 cells. (A) Example of CH12F3 FACS plot of indicated genotypes 4 days after stimulation with anti‐CD40, IL‐4, and TGF‐β. (B) CSR summary of six experiments of two WT (pooled) and three Paxx −/− (pooled) CH12F3 cells. Aid −/− CH12F3 cells were used to establish background levels of experiments. Multiple comparisons between groups were performed using GraphPad Prism 7.03 (La Jolla, CA, USA) and one‐way ANOVA. (C) Detection of PAXX protein by WB in WT and Paxx −/− CH12F3 cells. β‐Actin was used as a loading control. (D) Detection of AID protein using WB. UNG2 was used as a loading control. ‘+’ indicates cells stimulated with anti‐CD40, IL‐4 and TGF‐β. ‘−’ indicates unstimulated cells. AID expression was induced and detected in stimulated WT cells; AID band was absent before and after stimulation of Aid −/− cells. (E) Sensitivity of WT and Paxx −/− cells to DSB‐inducing agent zeocin. Numbers represent cell count normalized to mock‐treated controls. Three experiments with three independent clones were performed. Error bars represent SD.

Sensitivity of Paxx CH12F3 cells to DSBs

To examine whether PAXX is required for DSBs repair in murine lymphoid cells, we treated WT and Paxx −/− CH12F3 lines with the DSB‐inducing agent zeocin. Contrary to HAP1, Paxx −/− CH12F3 cells showed higher levels of sensitivity to zeocin when compared to parental WT lines (Fig. 2E). In addition, we examined proliferation of WT and three Paxx −/− CH12F3 lines by counting cells every 12 hours up to 72 hours. In three independent experiments, all the clones proliferated with similar speed and there was no difference in the cell cycle distribution (not shown). We concluded that PAXX is required for optimal DNA repair of zeocin‐induced DSBs in murine cell lines, although it is dispensable for CSR.

Discussion

Here, we purchased and characterized PAXX‐deficient human fibroblast‐like HAP1 cells (Horizon Discovery) and generated murine lymphoid CH12F3 cell lines at our own laboratory. We concluded that PAXX is dispensable for CSR and has a modest impact on cell resistance to DSB‐inducing agents such as etoposide and zeocin. Previous studies had controversial conclusions on the role of PAXX in DNA repair. For instance, significantly increased sensitivity to ionizing radiation was observed in Paxx‐knockout murine pro‐B cells 11, 12, mouse embryonic fibroblasts 11, chicken DT40 cells 7, and human PAXX‐knockdown U2OS cells 5, 6. PAXX knockout, however, resulted in no change in sensitivity to DSB‐inducing agent zeocin in human embryonic kidney cells 28 and doxorubicin in chicken DT40 cells 7. We explain this discrepancy by two main reasons. First, cell lines from different species were used in the studies, including chicken, mouse, and human. Second, distinct ways to induce DSBs were selected, including ionizing radiation, zeocin, doxorubicin, and etoposide. In addition, RAG‐ and AID‐/UNG‐mediated semiphysiological systems were used to study effect of PAXX deficiency on V(D)J recombination and CSR. In addition, slower proliferation of PAXX‐, XLF‐, and XRCC4‐deficient cells when compared to parental cell lines might be a specific feature of HAP1 and one may speculate that it depends on the transformation status or cell line origin. Similar proliferation defect was observed in the NHEJ‐deficient DT40 cells in our previous studies 7. Although in the current study PAXX has no or minor effect on the NHEJ measured as the CSR or indirectly assayed as the sensitivity to DSB‐inducing agents, genetic models used by us and our colleagues revealed functional overlap of PAXX with XLF [7, 10, 11, 12, 14]. It is possible that PAXX complements or substitutes other DNA repair factors; for example, accessory NHEJ‐ or ATM‐dependent DNA damage signaling proteins, and complex genetic models are required to identify its functions.

Author contributions

AD, MX, RGF, CB, NL, SS, KTPH, and VO planned and performed experiments and interpreted results. BK, ML, and PAA provided Aid −/− CH12F3 cell lines and expertise in CRISPR/Cas9 experiments. VO wrote the manuscript.
  27 in total

1.  Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair.

Authors:  Valentyn Oksenych; Frederick W Alt; Vipul Kumar; Bjoern Schwer; Duane R Wesemann; Erica Hansen; Harin Patel; Arthur Su; Chunguang Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.

Authors:  Peter Ahnesorg; Philippa Smith; Stephen P Jackson
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

Review 3.  Base excision repair.

Authors:  Hans E Krokan; Magnar Bjørås
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

4.  PAXX and XLF DNA repair factors are functionally redundant in joining DNA breaks in a G1-arrested progenitor B-cell line.

Authors:  Vipul Kumar; Frederick W Alt; Richard L Frock
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

5.  Deficiency of XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in lymphocytes.

Authors:  Putzer J Hung; Bo-Ruei Chen; Rosmy George; Caleb Liberman; Abigail J Morales; Pedro Colon-Ortiz; Jessica K Tyler; Barry P Sleckman; Andrea L Bredemeyer
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

6.  DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.

Authors:  Takashi Ochi; Andrew N Blackford; Julia Coates; Satpal Jhujh; Shahid Mehmood; Naoka Tamura; Jon Travers; Qian Wu; Viji M Draviam; Carol V Robinson; Tom L Blundell; Stephen P Jackson
Journal:  Science       Date:  2015-01-09       Impact factor: 47.728

7.  Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development.

Authors:  Xiangyu Liu; Wenxia Jiang; Richard L Dubois; Kenta Yamamoto; Zachary Wolner; Shan Zha
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

8.  A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

Authors:  Y Gao; Y Sun; K M Frank; P Dikkes; Y Fujiwara; K J Seidl; J M Sekiguchi; G A Rathbun; W Swat; J Wang; R T Bronson; B A Malynn; M Bryans; C Zhu; J Chaudhuri; L Davidson; R Ferrini; T Stamato; S H Orkin; M E Greenberg; F W Alt
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway.

Authors:  Mengtan Xing; Mingrui Yang; Wei Huo; Feng Feng; Leizhen Wei; Wenxia Jiang; Shaokai Ning; Zhenxin Yan; Wen Li; Qingsong Wang; Mei Hou; Chunxia Dong; Rong Guo; Ge Gao; Jianguo Ji; Shan Zha; Li Lan; Huanhuan Liang; Dongyi Xu
Journal:  Nat Commun       Date:  2015-02-11       Impact factor: 14.919

10.  Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

Authors:  Gang Li; Frederick W Alt; Hwei-Ling Cheng; James W Brush; Peter H Goff; Mike M Murphy; Sonia Franco; Yu Zhang; Shan Zha
Journal:  Mol Cell       Date:  2008-09-05       Impact factor: 17.970

View more
  13 in total

Review 1.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

2.  An in vivo study of the impact of deficiency in the DNA repair proteins PAXX and XLF on development and maturation of the hemolymphoid system.

Authors:  Stefania Musilli; Vincent Abramowski; Benoit Roch; Jean-Pierre de Villartay
Journal:  J Biol Chem       Date:  2020-01-08       Impact factor: 5.157

3.  Absence of XRCC4 and its paralogs in human cells reveal differences in outcomes for DNA repair and V(D)J recombination.

Authors:  Brian Ruis; Amy Molan; Taylor Takasugi; Eric A Hendrickson
Journal:  DNA Repair (Amst)       Date:  2019-11-12

4.  Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.

Authors:  Mengtan Xing; Valentyn Oksenych
Journal:  FEBS Open Bio       Date:  2019-06-12       Impact factor: 2.693

5.  Non-Homologous End Joining Factors XLF, PAXX and DNA-PKcs Maintain the Neural Stem and Progenitor Cell Population.

Authors:  Raquel Gago-Fuentes; Valentyn Oksenych
Journal:  Biomolecules       Date:  2020-12-28

6.  DNA Damage Response.

Authors:  Valentyn Oksenych; Denis E Kainov
Journal:  Biomolecules       Date:  2021-01-19

7.  Generation of a Mouse Model Lacking the Non-Homologous End-Joining Factor Mri/Cyren.

Authors:  Sergio Castañeda-Zegarra; Camilla Huse; Øystein Røsand; Antonio Sarno; Mengtan Xing; Raquel Gago-Fuentes; Qindong Zhang; Amin Alirezaylavasani; Julia Werner; Ping Ji; Nina-Beate Liabakk; Wei Wang; Magnar Bjørås; Valentyn Oksenych
Journal:  Biomolecules       Date:  2019-11-28

8.  Corrigendum to: Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.

Authors: 
Journal:  FEBS Open Bio       Date:  2020-01-06       Impact factor: 2.792

9.  Corrigendum to: Robust DNA repair in PAXX-deficient mammalian cells.

Authors: 
Journal:  FEBS Open Bio       Date:  2020-01-06       Impact factor: 2.792

10.  Mediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF.

Authors:  Carole Beck; Sergio Castañeda-Zegarra; Camilla Huse; Mengtan Xing; Valentyn Oksenych
Journal:  Biomolecules       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.